Idioma:

The role of peripheral adenosine receptors in glutamate-induced pain nociceptive behavior

Macedo-Júnior, S. J. ; Nascimento, F. P. ; Luiz-Cerutti, M. ; Santos, A. R. S.

Purinergic signalling, 2021-06, Vol.17 (2), p.303-312 [Revista revisada por pares]

Dordrecht: Springer Netherlands

Texto completo disponible

Citas Citado por

Acciones

Título:
The role of peripheral adenosine receptors in glutamate-induced pain nociceptive behavior
Autor: Macedo-Júnior, S. J. ; Nascimento, F. P. ; Luiz-Cerutti, M. ; Santos, A. R. S.
Materias: Adenosine ; Adenosine A1 Receptor Agonists - pharmacology ; Adenosine A1 Receptor Antagonists - pharmacology ; Adenosine A2 Receptor Agonists - pharmacology ; Adenosine A2 Receptor Antagonists - pharmacology ; Agonists ; Animals ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Female ; Foot ; Glutamates - administration & dosage ; Human Physiology ; Injection ; Injections ; Inosine - pharmacology ; Male ; Mice ; Neurosciences ; Nociception - drug effects ; Original ; Original Article ; Pain - chemically induced ; Pain - psychology ; Pain Measurement - drug effects ; Pain perception ; Peripheral Nervous System - drug effects ; Pharmacology/Toxicology ; Receptor mechanisms ; Receptor, Adenosine A2A - drug effects ; Receptors, Purinergic P1 - drug effects ; Statistical analysis
Es parte de: Purinergic signalling, 2021-06, Vol.17 (2), p.303-312
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descripción: The role of peripheral adenosine receptors in pain is a controversial issue and seems to be quite different from the roles of spinal and central adenosine receptors. The present study is aimed at clarifying the role of these receptors in peripheral nociception. To clarify this, studies were done on Swiss mice with adenosine receptor agonists and antagonists. Nociceptive behavior was induced by subcutaneous injection of glutamate (10 μmol) into the ventral surface of the hind paw of mice. Statistical analyses were performed by one-way ANOVA followed by the Student-Newman-Keuls post hoc test. Results showed that intraplantar (i.pl.) administration of N6-cyclohexyl-adenosine (CHA), an adenosine A1 receptor agonist, at 1 or 10 μg/paw significantly reduced glutamate-induced nociception ( p <0.01 and p <0.001 vs. vehicle, respectively, n =8−10). In contrast, i.pl. injection of hydrochloride hydrate (CGS21680, an adenosine A2A receptor agonist) (1 μg/paw) induced a significant increase in glutamate-induced nociception compared to the vehicle ( p <0.05, n =8), while 4-(-2-[7-amino-2-{2-furyl}{1,2,4}triazolo{2,3-a} {1,3,5}triazin-5-yl-amino]ethyl)phenol (ZM241385, an adenosine A2A receptor antagonist) (20 μg/paw) caused a significant reduction ( p <0.05, n =7−8). There were no significant effects on i.pl. administration of four additional adenosine receptor drugs—8-cyclopentyl-1,3-dipropylxanthine (DPCPX, an A1 antagonist, 1–10 μg/paw), N(6)-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)-ethyl]adenosine (DPMA, an A2B agonist, 1–100 μg/paw), alloxazine (an A2B antagonist, 0.1–3 μg/paw), and 2-hexyn-1-yl-N(6)-methyladenosine (HEMADO) (an A3 agonist, 1–100 μg/paw) ( p >0.05 vs. vehicle for all tests). We also found that prior administration of DPCPX (3 μg/paw) significantly blocked the anti-nociceptive effect of CHA (1 μg/paw) ( p <0.05, n =7–9). Similarly, ZM241385 (20 μg/paw) administered prior to CGS21680 (1 μg/paw) significantly blocked CGS21680-induced exacerbation of nociception ( p <0.05, n =8). Finally, inosine (10 and 100 μg/paw), a novel endogenous adenosine A1 receptor agonist recently reported by our research group, was also able to reduce glutamate-induced nociception ( p <0.001 vs. vehicle, n =7–8). Interestingly, as an A1 adenosine receptor agonist, the inosine effect was significantly blocked by the A1 antagonist DPCPX (3 μg/paw) ( p <0.05, n =7−9) but not by the A2A antagonist ZM241385 (10 μg/paw, p >0.05). In summary, these results demonstrate for the first time that i.pl administration of inosine induces an anti-nociceptive effect, similar to that elicited by CHA and possibly mediated by peripheral adenosine A1 receptor activation. Moreover, our results suggest that peripheral adenosine A2A receptor activation presents a pro-nociceptive effect, exacerbating glutamate-induced nociception independent of inosine-induced anti-nociceptive effects.
Editor: Dordrecht: Springer Netherlands
Idioma: Inglés

Enlaces

View this record in MEDLINE/PubMed

Volver a la lista de resultados

Anterior Resultado 3 Siguiente Ir a la siguiente página

Realización: Logos de Redes Sociales:

The role of peripheral adenosine receptors in glutamate-induced pain nociceptive behavior

Macedo-Júnior, S. J. ; Nascimento, F. P. ; Luiz-Cerutti, M. ; Santos, A. R. S.

Dordrecht: Springer Netherlands

Buscando en bases de datos remotas, por favor espere